Do intronic mutations affecting splicing of WT1 exon 9 cause Frasier syndrome?

Journal of Medical Genetics

Volumn 35, Issue 1, 1998, Pages 45-48

  Kikuchi, Haruhito ^a   Takata, Ayako ^a   Akasaka, Yoshikiyo ^b   Fukuzawa, Ryuji ^a   Yoneyama, Hiroshi ^a   Kurosawa, Yoshihiro ^a   Honda, Masataka ^c   Kamiyama, Yasunori ^d   Hata, Jun Ichi ^a  

^a KEIO UNIVERSITY   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Tokyo Metropol Kiyose Children's H ^*  (Japan)

^d Imperial Foundation Saiseikai Utsunomiya Hospital   (Japan)

Author keywords

Frasier syndrome; Intronic mutation; WT1 gene

Indexed keywords

LYSINE; PROTEIN; SERINE; THREONINE; ZINC FINGER PROTEIN;

ADULT; ALTERNATIVE RNA SPLICING; ARTICLE; CANCER GENETICS; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DENYS DRASH SYNDROME; DNA SEQUENCE; DONOR SITE; EXON; FEMALE; FRASIER SYNDROME; GENE FUNCTION; GENE MUTATION; GONAD DEVELOPMENT; HUMAN; HUMAN CELL; INTRON; KIDNEY DEVELOPMENT; KIDNEY DISEASE; MALE; NEPHROBLASTOMA; ORGANOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DOMAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031972063     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.35.1.45     Document Type: Article

References (19)

1. Call KM, Glaser T, Ito CY, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990,60:509-20.
2. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GAP. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 1990;343:774-8
3. Haber DA, Sohn RL, Buckler AJ, Pelletier H, Call KM, Housman DE. Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci USA 1991;88:9618-22.
4. Pritchard-Jones K, Fleming S, Davidson D, et al. The candidate Wilms' tumour gene is involved in genitourinary development. Nature 1990;346:194-7.
5. Pritchard-Jones K, Fleming S. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis. Oncogene 1991;6:2211-20.
6. Pelletier J, Bruening W, Kashtan CE, et al. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991;67:437-47.
7. Bruening W, Bardeesy N, Silverman BL, et al. Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development. Nat Genet 1992;1:144-8.
8. König A, Jakubiczka S, Wieacker P, Schlösser HW, Gessler M. Further evidence that imbalance of WT1 isoforms may be involved in Denys-Drash syndrome. Hum Mol Genet 1993;2:1967-8.
9. Bardeesy N, Zabel B, Schmitt K, Pelletier J. WT1 mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominant-negative fashion. Genomics 1994;21:663-5.
10. Moorthy AV, Chesney RW, Lubinsky M. Chronic renal failure and XY gonadal dysgenesis: "Frasier" syndrome - a commentary on reported cases. Am J Med Genet Suppl 1987;3:297-302.
11. Kikuchi H, Akasaka Y, Kurosawa Y, Yoneyama H, Kato S, Hata J. A critical mutation in both WT1 alleles is not sufficient to cause Wilms' tumor. FEBS Lett 1995;360:26-8.
12. Habib R, Loirat C, Gubler MC, et al. The nephropathy associated with male pseudohermaphroditism and Wilms' tumor (Drash syndrome): a distinctive glomerular lesion -report of 10 cases. Clin Nephrol 1985;24:269-78.
13. Coppes MJ, Huff V, Pelletier J. Denys-Drash syndrome: relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1. J Pediatr 1993;123:673-8.
14. Mueller RF. The Denys-Drash syndrome. J Med Genet 1994;31:471-7.
15. Eddy AA, Mauer SM. Pseudohermaphroditism, glomerulopathy, and Wilms tumor (Drash syndrome): frequency in end-stage renal failure. J Pediatr 1985;106:584-7.
16. Poulat F, Morin D, König A, et al. Distinct molecular origins for Denys-Drash and Frasier syndromes. Hum Genet 1993;91:285-6.
17. Larsson SH, Charlieu J, Miyagawa K, et al. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 1995;81:391-401.
18. Drummond IA, Madden SL, Rohwer-Nutter P, Bell GI, Sukhatme VP, Rauscher FJ III. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science 1992;257:674-8.
19. Rauscher FJ III, Morris JF, Tournary OE, Cook DM, Curran T. Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 1990;250:1259-62.